Evidence map›Paper›PMID 28825709›Full record

ArticleNature2017

Ascorbate regulates haematopoietic stem cell function and leukaemogenesis.

Michalis Agathocleous, Corbin E Meacham, Rebecca J Burgess, Elena Piskounova, Zhiyu Zhao, Genevieve M Crane, Brianna L Cowin, Emily Bruner, Malea M Murphy, Weina Chen and 4 more

2 registry-linked trialsOpen access · greenAbstract read
In one paragraph

Article in Nature, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 340 papers.

0numbers the graph read from it
0cells of the map it votes in
340citing papers in PubMed
33.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03682029 naunknown statusnot on this map

Epigenetics, Vitamin C, and Abnormal Hematopoiesis - Role of Vitamin C in Epigenetic Regulation in Hematopoiesis Sub-Study on CCUS, Low-Risk MDS, and CMML-0/1

TypeinterventionalSponsorRigshospitalet, DenmarkRan2017 to 2025Enrolled109ConditionsMyelodysplastic Syndromes, Chronic Myelomonocytic Leukemia-1, CytopeniaArmsVitamin C (ascorbic acid), Placebo
NCT04344184 phase2completednot on this mapstarted 2020, after this paper: background citation

SAFEty Study of Early Infusion of Vitamin C for Treatment of Novel Coronavirus Acute Lung Injury (SAFE EVICT CORONA-ALI)

TypeinterventionalSponsorVirginia Commonwealth UniversityRan2020 to 2022Enrolled47ConditionsCOVID-19, Lung Injury, Acute, Kidney InjuryArmsL-ascorbic acid, Placebo
3 · Its place in the literature

Who cites it

340 citing papers in PubMed, 533 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Mechanisms of Thrombocytosis in Iron-Deficiency Anemia.European journal of haematology · 2026
    Review
  5. Loss of TCA cycle turning promotes stem cell function.bioRxiv : the preprint server for biology · 2026
    Article
  6. Article
  7. Hematopoietic Stem Cell Metabolism during Stress and Aging.Advances in geriatric medicine and research · 2026
    Article
  8. Exacerbation of inflammatory bone loss in TET2-driven clonal hematopoiesis.Journal of immunology (Baltimore, Md. : 1950) · 2026
    Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Review
  14. Review
  15. Review
  16. Review
  17. Review
  18. Article
  19. Stem cell functionbioRxiv : the preprint server for biology · 2026
    Article
  20. Review

280 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors at 2 institutions in 1 country.

Michalis AgathocleousChildren's Research Institute and the Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, Texas 75390, USA.
Corbin E MeachamChildren's Research Institute and the Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, Texas 75390, USA.
Rebecca J BurgessChildren's Research Institute and the Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, Texas 75390, USA.
Elena PiskounovaChildren's Research Institute and the Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, Texas 75390, USA.
Zhiyu ZhaoChildren's Research Institute and the Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, Texas 75390, USA.
Genevieve M CraneChildren's Research Institute and the Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, Texas 75390, USA.
Brianna L CowinChildren's Research Institute and the Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, Texas 75390, USA.
Emily BrunerChildren's Research Institute and the Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, Texas 75390, USA.
Malea M MurphyChildren's Research Institute and the Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, Texas 75390, USA.
Weina ChenDepartment of Pathology, University of Texas Southwestern Medical Center, Dallas, Texas 75390, USA.
Gerald J SpangrudeDepartment of Medicine, University of Utah, Salt Lake City, Utah, USA.
Zeping HuChildren's Research Institute and the Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, Texas 75390, USA.
Ralph J DeBerardinisChildren's Research Institute and the Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, Texas 75390, USA.
Sean J MorrisonChildren's Research Institute and the Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, Texas 75390, USA.
The University of Texas Southwestern Medical Center · USUniversity of Utah · US

Funding

The Regulation of Stem Cell AgingR37AG024945 · NIA · UT SOUTHWESTERN MEDICAL CENTER · PI MORRISON, SEAN J · 2009 to 2018
$3.1M
The regulation of protein synthesis in stem cellsR01DK100848 · NIDDK · UT SOUTHWESTERN MEDICAL CENTER · PI MORRISON, SEAN J · 2014 to 2016
$898k
Howard Hughes Medical InstituteNIA NIH HHS R37 AG024945NIDDK NIH HHS R01 DK100848
6 · The paper itself

Abstract

Stem-cell fate can be influenced by metabolite levels in culture, but it is not known whether physiological variations in metabolite levels in normal tissues regulate stem-cell function in vivo. Here we describe a metabolomics method for the analysis of rare cell populations isolated directly from tissues and use it to compare mouse haematopoietic stem cells (HSCs) to restricted haematopoietic progenitors. Each haematopoietic cell type had a distinct metabolic signature. Human and mouse HSCs had unusually high levels of ascorbate, which decreased with differentiation. Systemic ascorbate depletion in mice increased HSC frequency and function, in part by reducing the function of Tet2, a dioxygenase tumour suppressor. Ascorbate depletion cooperated with Flt3 internal tandem duplication (Flt3

Indexed as

AnimalsAscorbic AcidAscorbic Acid DeficiencyCarcinogenesisDioxygenasesDNA-Binding ProteinsFemalefms-Like Tyrosine Kinase 3Hematopoietic Stem CellsHumansLeukemiaMaleMetabolomicsMiceMyelopoiesisProto-Oncogene ProteinsAscorbic AcidDioxygenasesDNA-Binding ProteinsFlt3 protein, mousefms-Like Tyrosine Kinase 3Proto-Oncogene ProteinsTet2 protein, mouse

Identifiers

PMID28825709
PMCPMC5910063
OpenAlexW2746373891

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.